tm
Seeing Is Believing
tm
Seeing Is Believing
CDTX is currently covered by 1 analysts with an average potential upside of $4.47 (173.88%) from yesterday's end of day stock price of $0.74. Cidara Therapeutics activity chart has currently 9 price targets and 15 ratings on display.
Analysts average stock forecasts to be materialized ratio is 19.44% with an average time for these price targets to be met of 27 days.
Highest price target for CDTX is $2, Lowest price target is $1, average price target is $1.5.
Most recent stock forecast was given by ED ARCE from HCWAINWRIGHT on 22-Sep-2023. First documented stock forecast 11-May-2015.
Currently, out of the existing stock ratings of CDTX - 3 which are a Buy (100%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
6
$5.06 (538.30%)
6
2 months 18 days ago
0/7 (0%)
$4.87 (432.82%)
Buy
5
$4.14 (481.40%)
5
4 months 9 days ago
0/2 (0%)
$3.68 (295.67%)
Buy
1 years 7 months 26 days ago
1/1 (100%)
$-2.15 (-14.19%)
158
Buy
8
1 years 7 months 26 days ago
0/3 (0%)
$6.41 (284.34%)
Buy
5
$4.06 (431.91%)
8
3 years 3 months 14 days ago
0/3 (0%)
$3.46 (106.54%)
What is CDTX (Cidara Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CDTX (Cidara Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CDTX (Cidara Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CDTX (Cidara Therapeutics)?
Which analyst is the currently most bullish on CDTX (Cidara Therapeutics)?
Which analyst is the currently most reserved on CDTX (Cidara Therapeutics)?
